Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
| Status: | Terminated |
|---|---|
| Conditions: | Lung Cancer, Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/4/2018 |
| Start Date: | May 2004 |
| End Date: | May 2007 |
Phase II Study to Evaluate the Efficacy and Safety of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
The purpose of this study is to develop new treatments that will hopefully result in the
relief of symptoms and prolongation of life. For this reason, your doctors have offered you
treatment with a new experimental drug called PS 341.
relief of symptoms and prolongation of life. For this reason, your doctors have offered you
treatment with a new experimental drug called PS 341.
Inclusion Criteria:
- Patients must have confirmed NSCLC (squamous, adeno- and large cell anaplastic
carcinoma)stage III B or Stage IV.
No prior chemotherapy regimen Patients must have adequate organ and marrow function
Exclusion Criteria:
- Untreated symptomatic brain metastasis Patients with known HIV positivity
We found this trial at
5
sites
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
Click here to add this to my saved trials
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials
Click here to add this to my saved trials
Jacobi Medical Center In 1955, the NYC Department of Hospitals opened a new, specialized care...
Click here to add this to my saved trials
Click here to add this to my saved trials